Methodological issues in radiation dose-volume outcome analyses: Summary of a joint AAPM/NIH workshop

Medical Physics

Volumn 29, Issue 9, 2002, Pages 2109-2127

  Deasy, Joseph O ^a   Niemierko, Andrzej ^b   Herbert, Donald ^c   Yan, Di ^d   Jackson, Andrew ^e   Ten Haken, Randall K ^f   Langer, Mark ^g   Sapareto, Steve ^h  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^d WILLIAM BEAUMONT HOSPITAL   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

^g INDIANA UNIVERSITY   (United States)

^h BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

Author keywords

NTCP; Outcomes analysis; TCP; Volume effects

Indexed keywords

CLINICAL RESEARCH; LEARNING TO RANK; ONCOLOGY; PREDICTIVE ANALYTICS; RADIATION EFFECTS;

DOSE-ESCALATION STUDY; EQUIVALENT UNIFORM DOSE; NATIONAL INSTITUTES OF HEALTH; NTCP; OPTIMIZED TREATMENT PLANNING; OUTCOMES ANALYSIS; TUMOR CONTROL PROBABILITY; VOLUME EFFECT;

UNCERTAINTY ANALYSIS;

ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; DATA ANALYSIS; DOSIMETRY; LIVER; LUNG; MEDICAL SOCIETY; METHODOLOGY; MODEL; ONCOLOGY; PHYSICS; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; RADIATION SICKNESS; RADIOTHERAPY; TREATMENT PLANNING;

ANIMALIA;

EID: 0036732688     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1501473     Document Type: Article

References (131)

1. Reporting and analyzing dose distributions: A concept of equivalent uniform dose
2. Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma
3. IMRT optimization based on the generalized Equivalent Uniform Dose (EUD)
4. Treatment volume and tissue tolerance
5. Modeling of normal tissue response to radiation: The critical volume model
6. A generalized concept of Equivalent Uniform Dose
7. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations
8. Complication probability as assessed from dose-volume histograms
9. Quality assessment and improvement of dose-response models: Some effects of study weaknesses on study findings. C'est magnifique?
10. A unified model of tissue response to radiation
11. A prospective study of salivary function sparing in patients with head and neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results
12. Robustness in the strategy of scientific model building
13. Quality assessment and improvement of dose response models: Some effects of study weaknesses on study findings. C'est magnifique?
14. The quality of medical literature: An analysis of validation assessments
15. The urgent need to improve health care quality
16. The status of health assessment 1994
17. Problems induced by meta-analysis
18. Meta-analysis in clinical medicine
19. The Cochrane collaboration. Preparing, maintaining, and disseminating systematic reviews of the effects of health care
20. Gray zones of clinical practice: Some limits to evidence-based medicine
21. Surveillance of medical technologies
22. Falsificationism and clinical trials
23. Using scientific information to improve quality of health care
24. Response surfaces for binary events. An empirical basis for radiation oncology
25. An extreme value paradigm for the effect of size on target volume on end results in radiation oncology
26. An empirical extreme value model of the volume effect in radiation oncology
27. The determination of optimum conditions
28. The bivariate probit model of uncomplicated control of tumor: A heuristic exposition of the methodology
29. Beyond randomized clinical trials: Applying clinical experience in the treatment of patients with coronary artery disease
30. Date mining: Statistics and more
31. Nonlinear dynamics of physiological function and control
32. More is different
33. Modeling the effectiveness of radiation treatment
34. The use of the linear quadratic model in clinical radiation oncology can be defended on the basis of empirical evidence and theoretical argument
35. Overview of nonlinear dynamical systems and complexity theory
36. The probability of controlling an inhomogeneously irradiated tumour: A strategem for improving tumour control through partial tumour boosting
37. Tumor control probability models for nonuniform dose distributions
38. Selective boosting of tumor subvolumes
39. Partial tumor boosts: Even more attractive than theory predicts
40. Maximising local control by customising dose prescription for pelvic tumours
41. Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma
42. Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor control probability models
43. Intratumoral heterogeneity as a confounding factor in clonogenic assays for tumour radioresponsiveness
44. An introduction to the Bootstrap
45. A prospective study of salivary function sparing in patients with head and neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results
46. Uncertainties in outcome predictions for treatment planning
47. Bioeffect modeling of nonuniform dose distributions for paired organs
48. The utility of SPECT lung perfusion scans in minimizing and assessing the physiologic consequences of thoracic irradiation
49. Is repair of DNA strand break damage from ionizing radiation second-order rather than first-order? A simple explanation of apparently multiexponential repair
50. Biphasic cellular repair and implications for multiple field radiotherapy treatments
51. Dose-rate effects in intensity modulated radiation therapy
52. Three-dimensional verification of patient placement during radiotherapy using portal images
53. A model to accumulate the fractionated dose in a deforming organ
54. A generalization of adaptive radiotherapy and the registration of deformable dose distribution
55. Maximizing setup accuracy using portal images as applied to a conformal boost technique for prostatic cancer
56. An off-line strategy for constructing a patient-specific planning target volume for image guided adaptive radiotherapy of prostate cancer
57. Organ/patient positioning variation in external beam radiotherapy and its effects
58. Implementation of random positioning error in computerized radiation treatment planning systems as a result of fractionation
59. The linear-quadratic formula and progress in fractionated radiotherapy
60. Dose fractionation, dose rate and iso-effect relationships for normal tissue response
61. Tolerance of normal tissue to theraputic irradiation
62. Bowel complications after radiotherapy for carcinoma of the prostate: The volume effect
63. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: A randomised clinical trial
64. Late rectal bleeding following combined x-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma
65. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: Analysis of RTOG studies 7506 and 7706
66. Conformal irradiation of the prostate: Estimating long term rectal bleeding using dose-volume histograms
67. Late GI and GU complications in the treatment of prostate cancer
68. Estimation of the incidence of late bladder and rectum complications after high dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms
69. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): Multivariate analysis and dose-response
70. Late rectal bleeding after conformal radiotherapy of prostate cancer (II): Volume effects and dose volume histograms
71. Volume effects in external beam treatments of prostate cancer
72. Correlations between dose-surface histograms and the incidence of long-term rectal bleeding following conformal or conventional radiotherapy treatment of prostate cancer
73. A new method to determine dose-effect relations for local lung-function changes using correlated SPECT and CT data
74. Quantification of radiation-induced regional lung injury with perfusion imaging
75. The role of lung perfusion imaging in predicting the direction of radiation-induced changes in pulmonary function tests
76. Radiation dose-effect relations and local recovery in perfusion for patients with non-small-cell lung cancer
77. Uncertainties in CT-based treatment plans due to patient breathing
78. Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer
79. Escalated focal liver radiation and hepatic artery fluorodeoxyuridine for unresectable liver malignancies
80. Partial irradiation of the liver
81. Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer
82. Dose escalation in non-small cell lung cancer using 3-dimensional conformal radiation therapy: Update of a phase I trial
83. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients
84. Radiation-induced pulmonary injury: Symptomatic versus subclinical endpoints
85. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis
86. The treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model
87. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis
88. Dose escalation for non-small cell lung cancer using conformal radiation therapy
89. A conformal dose escalation protocol for the treatment of tumors in the lung or other normal tissues with parallel architecture
90. Use of Veff and iso-NTCP in the implementation of dose escalation protocols
91. Analysis of clinical complication data for radiation hepatitis using a parallel architecture model
92. The delay before onset of accelerated tumour cell repopulation during radiotherapy: A direct maximum-likelihood analysis of a collection of worldwide tumour-control data
93. Technical considerations in the use of 3-D beams in the abdomen
94. An application of dose volume histograms to treatment of intrahepatic malignancies with radiation
95. Treatment of cancers involving the liver and porta hepatis with external beam irradiation and intraarterial hepatic fluorodeoxyuridine
96. Complication probability as assessed from dose volume histograms
97. The use of 3-D dose volume analysis to predict radiation hepatitis
98. Calculation of complication probability factors for nonuniform normal tissue irradiation: The effective volume method
99. Deep inspiration breath-hold technique for lung tumors: The potential value of target immobilization and reduced lung density in dose escalation
100. The use of active breathing control (ABC) to reduce margin for breathing motion
101. Improvement of CT-based treatment planning models of abdominal targets using static exhale imaging
102. Potential benefits of eliminating planning target volume expansions for patient breathing in the treatment of liver tumors
103. A method for incorporating organ motion due to breathing into 3D dose calculations
104. Quantization of setup uncertainties in 3D dose calculations
105. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractioned-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited stage small-cell lung cancer
106. Concurrent cisplatin prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: A phase II study of the southwest oncology group (SWOG-9229)
107. Predicting radiation response
108. Physical and biological predictors of changes in whole lung function following thoracic irradiation
109. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)
110. CCRT for non-small cell lung cancer: Sensitivity of clinical gains to organ tolerance restrictions
111. Gain in target dose from using computer controlled radiotherapy (CCRT) in the treatment of non-small cell lung cancer
112. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small lung cancer
113. The effect on minimum tumor dose of restricting target-Dose inhomogeneity in optimized three-dimensional treatment of lung cancer
114. Three-dimensional radiation treatment planning study for patients with carcinoma of the lung
115. Treatment planning optimization based on response-surface modeling of cost function versus multiple constraints
116. A test of the claim that plan rankings are determined by relative complication and tumor control probabilities
117. Convex programming
118. The nucleus